Ludiomil

Ludiomil

 [loo´de-o-mil″]
trademark for a preparation of maprotiline hydrochloride, a tetracyclic antidepressant.

Ludiomil

a trademark for an antidepressant (maprotiline hydrochloride).

maprotiline

A tetracyclic antidepressant similar to tricyclic agents.
 
Indications
Major depression, bipolar disorder.

Adverse effects
Anticholinergic effects (e.g., dizziness, drowsiness, fatigue, dry mouth), orthostatic hypotension, sinus tachycardia or other arrhythmias, sexual dysfunction, rash, photosensitivity, confusion, seizures, liver toxicity, agranulocytosis, polyneuritis and other findings.

Special considerations
Should not be administered with MAOIs; may be toxic to the liver or kidneys; may cause seizures; may cause arrhythmias or heart failure.

Ludiomil®

Maprotiline, see there.

Ludiomil

A brand name for MAPROTILINE HYDROCHLORIDE.
References in periodicals archive ?
xx Aventyl, Budeprion SR, bupropion, Celexa, clomipramine, desipramine, Desyrel, Effexor, Effexor XR, Elavil, Emitrip, fluoxetine, fluvoxamine maleate, imipramine, Lexapro, Ludiomil, Luvox, maprotiline, mirtazapine, nefazodone, Norpramin, nortriptyline, Pamelor, paroxetine, Paxil, Paxil CR, Pexeva, Prozac, Prozac Weekly, Remeron, Serzone, Surmontil, Tofranil, Tofranil-PM, Trazodone, Vivactil, Wellbutrin, Wellbutrin SR, Wellbutrin XL, Zoloft Diabetes 250.
Continuing reports about dispensing errors over confusion with lamotrigine (Lamictal) and the antifungal terbinafine (Lamisil) have prompted the Food and Drug Administration to issue a warning in early December, Pharmacists may give lamotrigine in error to patients with prescriptions for a number of other drugs, most commonly Lamisil, lamivudine, Ludiomil, labetalol, and Lomotil, the FDA cautioned in its Safety Alert (www.
Lamisil (terbinafine HCl tablets) and Ludiomil (maprotiline HCl) are registered trademarks of Novartis Pharmaceuticals Corporation.
Antidepressants -- Elvail/Endep*, Aventyl/Panelor, Vivactyl, Tofranil/SK Pramine, Norpramin/Pertofrane, Sinequan/Adapin, Ascendin, Ludiomil, Prozac, Wellbutrin, Surmontil, lithium, Clozaril, Anmafranil.
Under the terms of the agreement, Invida will conduct distribution, registration, and marketing activities for products that include Carfergot, Apresoline, Locasalen, Neomercazole, Erythrocin, Eryped, Tofranil, Akineton, and Ludiomil.